New Delhi: Corona vaccination has been going on fast in the country for some time, while Johnson & Johnson Company has claimed that its vaccine with the same dose is effective in fighting the delta variant. Although the results of the new study are preliminary, they are promising. Researchers analyzed the blood of 10 people who had been vaccinated with the same dose of Johnson & Johnson. It was also tested against several other variants, including Delta.
In the same investigation, he found that the vaccine appeared to work against the new variant. Dr. Paul Staffels, Vice President and Chief Scientific Officer of Johnson & Johnson’s Executive Committee, said the new study strengthens the potential of the Johnson & Johnson Corona Vaccine to help protect the health of people globally. Earlier data has indicated that other vaccines made by Pfizer and Moderna are also likely to fight against the delta variant.
But some experts have expressed concern over Johnson & Johnson’s vaccine, which contains only one dose compared to others. Dr. Beth, Director, Center for Virology and Vaccine Research, Israel Deacons Medical Center. Dan Baroche, who helped lead the research, said, “I would say it’s reassuring. We also pointed out that we found that the Johnson & Johnson vaccine induces neutralizing antibodies. Baroch said that Another reassuring result of the study was that people vaccinated with Johnson & Johnson shots saw a stronger immune system response up to eight months later.
Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.